Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy

L. H. Markvardsen; T. Harbo; S. H. Sindrup; I. Christiansen; H. Andersen; J. Jakobsen;

doi:10.1111/ene.12513

Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy

European Journal of Neurology ◽

10.1111/ene.12513 ◽

2014 ◽

Vol 21 (12) ◽

pp. 1465-1470 ◽

Cited By ~ 49

Author(s):

L. H. Markvardsen ◽

T. Harbo ◽

S. H. Sindrup ◽

I. Christiansen ◽

H. Andersen ◽

...

Keyword(s):

Muscle Strength ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Faculty Opinions recommendation of Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726314797.793518841 ◽

2016 ◽

Author(s):

Kazim Sheikh ◽

Helmar Lehmann

Keyword(s):

Diffusion Tensor Imaging ◽

Peripheral Nerves ◽

Diffusion Tensor ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy

European Journal of Neurology ◽

10.1111/ene.14716 ◽

2021 ◽

Author(s):

Anna Lena Fisse ◽

Sean Fiegert ◽

Zornitsa Stoykova ◽

Jil Brünger ◽

Diamantis Athanasopoulos ◽

...

Keyword(s):

Muscle Strength ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study)

Clinical Neurophysiology ◽

10.1016/j.clinph.2019.11.053 ◽

2020 ◽

Vol 131 (3) ◽

pp. e9

Author(s):

I.N. Schaik ◽

V. Bril ◽

N. Geloven ◽

H.P. Hartung ◽

R.A. Lewis ◽

...

Keyword(s):

Maintenance Treatment ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Controlled Trial ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Practical Application ◽

Double Blind ◽

Double Blind Placebo ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin

Acta Neurologica Scandinavica ◽

10.1111/ane.13322 ◽

2020 ◽

Vol 142 (6) ◽

pp. 637-640 ◽

Cited By ~ 1

Author(s):

Anne‐Kathrine Ryltoft ◽

Ali Al‐Zuhairy ◽

Søren H. Sindrup ◽

Henning Andersen ◽

Lars K. Markvardsen

Keyword(s):

Quality Of Life ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Is grip strength compared to lower extremity measurements sufficient for capturing changes in muscle strength in chronic inflammatory demyelinating polyneuropathy?

Neuromuscular Disorders ◽

10.1016/j.nmd.2017.06.478 ◽

2017 ◽

Vol 27 ◽

pp. S227-S228

Author(s):

K. Knak ◽

L. Andersen ◽

L. Markvardsen

Keyword(s):

Muscle Strength ◽

Lower Extremity ◽

Grip Strength ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study

Clinical Neurophysiology ◽

10.1016/j.clinph.2019.11.050 ◽

2020 ◽

Vol 131 (3) ◽

pp. e7-e8

Author(s):

Amgad Shebl ◽

Billie L. Durn ◽

Vera Bril ◽

Ingemar S.J. Merkies ◽

Nan Geloven ◽

...

Keyword(s):

Intravenous Immunoglobulin ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Risk Profile ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Comparative Effectiveness of Intravenous Immunoglobulin (IVIg) and Subcutaneous Immunoglobulin (SCIg) versus Historical controls in Management of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RRNMF Neuromuscular Journal ◽

10.17161/rrnmf.v2i3.15706 ◽

2021 ◽

Vol 2 (3) ◽

Author(s):

Mamatha Pasnoor ◽

Mazen M. Dimachkie ◽

Byron Gajewski ◽

Lemuel Waitman ◽

Kim Kimminau ◽

...

Keyword(s):

Intravenous Immunoglobulin ◽

Comparative Effectiveness ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Inflammatory Demyelinating Polyneuropathy ◽

Historical Controls

Download Full-text

Infusion Parameters and Demographics of Patients With Chronic Inflammatory Demyelinating Polyneuropathy During Subcutaneous Immunoglobulin Self-Administration Training

Journal of Infusion Nursing ◽

10.1097/nan.0000000000000441 ◽

2021 ◽

Vol 44 (5) ◽

pp. 289-297

Author(s):

Elyse Murphy ◽

Chris Vanname ◽

Robert McNeill ◽

Melody Bullock ◽

Lisa Barrett ◽

...

Keyword(s):

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Self Administration ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study

Clinical Neurophysiology ◽

10.1016/j.clinph.2018.09.067 ◽

2019 ◽

Vol 130 (1) ◽

pp. e10

Author(s):

D. Cocito ◽

E. Peci ◽

G. Lauria Pinter ◽

P. Dacci ◽

A. Di Muzio ◽

...

Keyword(s):

Maintenance Treatment ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Controlled Trial ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Double Blind ◽

Double Blind Placebo ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Neurology ◽

10.1016/s1474-4422(17)30378-2 ◽

2018 ◽

Vol 17 (1) ◽

pp. 35-46 ◽

Cited By ~ 94

Author(s):

Ivo N van Schaik ◽

Vera Bril ◽

Nan van Geloven ◽

Hans-Peter Hartung ◽

Richard A Lewis ◽

...

Keyword(s):

Maintenance Treatment ◽

Chronic Inflammatory Demyelinating Polyneuropathy ◽

Demyelinating Polyneuropathy ◽

Subcutaneous Immunoglobulin ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Inflammatory Demyelinating Polyneuropathy

Download Full-text